UNICA IRIS Institutional Research Information System

PANI, FABIANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 79.458
NA - Nord America 1.989
AS - Asia 557
SA - Sud America 68
Continente sconosciuto - Info sul continente non disponibili 7
AF - Africa 3
OC - Oceania 1
Totale 82.083
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 78.725
US - Stati Uniti d'America 1.962
CN - Cina 291
UA - Ucraina 165
SG - Singapore 159
SE - Svezia 157
FR - Francia 101
DE - Germania 84
GB - Regno Unito 69
BR - Brasile 56
FI - Finlandia 42
NL - Olanda 31
KR - Corea 25
CA - Canada 17
VN - Vietnam 17
BE - Belgio 15
IN - India 15
IR - Iran 13
PL - Polonia 13
RU - Federazione Russa 12
TR - Turchia 10
EU - Europa 7
MX - Messico 7
CH - Svizzera 5
IE - Irlanda 5
AT - Austria 4
EC - Ecuador 4
ES - Italia 4
IQ - Iraq 4
LT - Lituania 4
AL - Albania 3
AR - Argentina 3
HK - Hong Kong 3
IL - Israele 3
JP - Giappone 3
PT - Portogallo 3
RO - Romania 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CZ - Repubblica Ceca 2
EG - Egitto 2
HR - Croazia 2
HU - Ungheria 2
ID - Indonesia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 82.083
Salva come PNG Salva come JPEG
Città #
Cagliari 73.825
Uta 1.108
Rome 296
Milan 292
Chandler 193
Woodbridge 172
Fairfield 142
Nyköping 124
Houston 109
Ashburn 106
Dearborn 105
Boardman 91
Singapore 84
Wilmington 84
Ann Arbor 72
Naples 71
Seattle 68
New York 63
Bologna 57
Cambridge 56
Shanghai 54
Florence 52
Jacksonville 43
Palermo 40
Nanjing 36
Santa Clara 36
Turin 36
Bari 33
Catania 33
Helsinki 33
Boston 31
The Dalles 27
Beijing 26
Genoa 24
Seoul 24
Padova 22
San Diego 18
San Mateo 18
Torino 18
Atlanta 17
Parma 17
Dong Ket 16
Avellino 15
Guangzhou 15
Hebei 15
Los Angeles 15
Pescara 15
Redwood City 15
Toronto 15
Zhengzhou 15
Jiaxing 14
Reggio Calabria 14
Shenyang 14
Mountain View 13
Nanchang 13
Brescia 12
London 12
Monza 12
Lauterbourg 11
Messina 11
Perugia 11
Salerno 11
Sassari 11
Verona 11
Baltimore 10
Foggia 10
Genova 10
Montecchio Maggiore 10
Rimini 10
Varazze 10
Bergamo 9
Brussels 9
Frankfurt am Main 9
Segrate 9
Changsha 8
Leawood 8
Lissone 8
Modena 8
Munich 8
Orange 8
Udine 8
Como 7
Giugliano in Campania 7
Livorno 7
Napoli 7
Nichelino 7
Norwalk 7
Redmond 7
Tianjin 7
Vicenza 7
Angri 6
Augusta 6
Düsseldorf 6
Hangzhou 6
Kunming 6
Lamezia Terme 6
Lucca 6
Novara 6
Nuremberg 6
Oristano 6
Totale 78.337
Salva come PNG Salva come JPEG
Nome #
L’iperplasia delle cellule “c” parafollicolari senza mutazione del protooncogene ret: descrizione e implicazioni diagnostiche di alcuni casi clinici. 4.850
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib: preliminary results from a single prospective cohort study. 4.805
Thyrospheres from B-CPAP cell line with BRAF and TERT promoter mutations have different functional and molecular features than parental cells 3.306
Associazione tra carcinoma papillare della tiroide e tiroidite cronica autoimmune: nuove conferme da un ampio studio prospettico. 3.093
High prevalence of papillary thyroid carcinoma in nodular Hashimoto's thyroiditis at the first diagnosis and during the follow-up 3.091
Regorafenib-induced hypothyroidism and cancer-related fatigue: is there a potential link? 2.911
Thyroid dysfunction and ultrasonography features in patients with metastatic colorectal cancer treated with Regorafenib. Results from a single centre prospective cohort study. 2.885
Risultati di un ampio studio prospettico sull’associazione tra la tiroidite di Hashimoto e il carcinoma papillare della tiroide. 2.869
Association between autoimmune thyroiditis and papillary thyroid carcinoma: new confirmations from a large prospective study. 2.864
Score ecografico del rischio di malignità dei noduli tiroidei (TI-RADS): risultati citologici di uno studio prospettico di noduli con tiroidite di Hashimoto vs noduli senza tiroidite di Hashimoto. 2.804
Characterizing the three-dimensional organization of telomeres in papillary thyroid carcinoma cells 2.728
Thyroid Autoimmunity and Thyroid Cancer: Review Focused on Cytological Studies 2.603
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.586
Thyroid dysfunction in disguise and treatment-related fatigue in the spotlight among metastatic colorectal cancer patients receiving regorafenib: Implications for clinical management. 2.546
Aggressive differentiated thyroid cancer with multiple metastases and NRAS and TERT promoter mutations: A case report 2.418
Thyroid imaging reporting and data system score: evaluation of risk stratification in thyroid nodules with Hashimoto’s Thyroiditis and thyroid nodules without Hashimoto’s thyroiditis underwent fine-needle aspiration cytology: results from a prospective study. 2.393
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. Risultati di uno studio prospettico. 2.363
Thyroid dysfunction in patients with metastatic carcinoma treated with Sunitinib: is thyroid autoimmunity involved? 2.304
Alterazioni tiroidee funzionali e morfologiche in pazienti affetti da carcinoma del colon-retto metastatico in trattamento con Regorafenib. 2.275
Off-target effects and clinical outcome in metastatic colorectal cancer patients receiving regorafenib: The TRIBUTE analysis 2.271
HYPOTHYROIDISM AND THYROID AUTOIMMUNITY AS A PROGNOSTIC BIOMARKER OF BETTER RESPONSE IN METASTATIC CANCER LONG SURVIVORS TREATED WITH SUNITINIB 2.185
The role of “closed abdomen” hyperthermic intraperitoneal chemotherapy (HIPEC) in the palliative treatment of neoplastic ascites from peritoneal carcinomatosis: report of a single-center experience 2.172
Higher prevalence of thyroid cancer in patients with thyroid nodules (TN) and Hashimoto’s Thyroiditis (HT) at the first clinical evaluation compared to TN patients without thyroid autoimmunity and HT patients without TN followed-up for 1-9 years. 2.146
Prognostic Value of Thyroid Hormone Ratios in Patients With Advanced Metastatic Colorectal Cancer Treated With Regorafenib: The TOREADOR Study 2.051
Ipotiroidismo e autoimmunità tiroidea in pazienti affetti da carcinoma renale metastatico trattati con sunitinib con un follow-up di 30 mesi. 2.041
Prevalence of thyroid cancer in patients with hashimoto’s thyroiditis with or without nodules at the first clinical evaluation and in the subsequent follow-up. 1.963
Differenze nella prevalenza del carcinoma papillare della tiroide (PTC) nei pazienti con noduli tiroidei (NT) associati a tiroidite di Hashimoto (HT) alla prima diagnosi rispetto ai pazienti con NT senza TH e ai pazienti con TH esordita prima dei NT. 1.940
Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features 1.940
Hypothyroidism and thyroid autoimmunity in metastatic renal cell carcinoma patients treated with sunitinib: 2 years follow-up of long survivors from a single centre experience. 1.898
Hashimoto’s thyroiditis and thyroid cancer: a case-control study of unselected patients with thyroid nodules submitted to cytological and hystological examination. 1.869
Thyroid dysfunction and ultrasonography features in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors. Preliminary results from a prospective cohort study. 1.293
Embolization of iliac metastasis during lenvatinib treatment in patient with advanced Hürthle cell thyroid carcinoma 1.173
Endocrinological, metabolic and clinical features of treatment with oral contraceptive formulation containing ethinylestradiol plus chlormadinone acetate in nonobese women with polycystic ovary syndrome 749
Caratteristiche cliniche, endocrine, e metaboliche di donne non obese affette da sindrome dell'ovaio policistico (PCOS) dopo sei cicli di trattamento con la formulazione contraccettiva estroprogestinica orale monofasica contenente 30 mcg di etinilestradiolo (EE) e 2 mg di clormadinone acetato (CMA) 741
CARAMEL study: Clinical prognostic biomarkers for ipilimumab-related outcome in metastatic melanoma patients. 117
Totale 82.243
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020715 0 0 0 0 0 0 0 0 0 0 247 468
2020/202124.462 680 970 879 7.417 4.632 2.818 1.479 1.421 721 1.424 1.253 768
2021/20224.549 598 367 245 458 349 338 287 239 444 437 390 397
2022/20236.015 560 912 896 460 414 375 306 419 424 369 574 306
2023/20246.317 405 242 260 391 568 958 981 569 306 402 624 611
2024/20259.997 2.590 2.943 1.199 1.020 559 620 717 74 136 113 26 0
Totale 82.243